Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Stem Cell Research

  Free Subscription


Articles published in Leuk Lymphoma

Retrieve available abstracts of 63 articles:
HTML format
Text format



Single Articles


    March 2017
  1. ANGUITA-COMPAGNON AT, Dibarrart MT, Paredes L, Araos D, et al
    Peripheral blood stem cell mobilization with a single dose of PEG-filgrastim in patients with multiple myeloma previously treated with radiotherapy.
    Leuk Lymphoma. 2017 Mar 16:1-4. doi: 10.1080/10428194.2017.1300895.
    PubMed     Text format    


  2. COCITO F, Mangiacavalli S, Bernasconi P, Colombo AA, et al
    Long-term control of extensive refractory chronic graft versus host disease in a multiple myeloma relapsing after allogeneic transplant. A case report.
    Leuk Lymphoma. 2017 Mar 13:1-2. doi: 10.1080/10428194.2017.1300890.
    PubMed     Text format    


    February 2017
  3. NICOL C, Henry C, Couturier MA, Delepine P, et al
    Biosimilars of filgrastim in autologous stem cell transplantation: certain differences for myeloma patients only.
    Leuk Lymphoma. 2017 Feb 7:1-3. doi: 10.1080/10428194.2017.1285025.
    PubMed     Text format    


    January 2017
  4. GREIL C, Kiote-Schmidt C, Fink G, Ihorst G, et al
    Successful peripheral blood stem cell mobilization with a cost-efficient single fixed-dose plerixafor schedule in poor mobilizers.
    Leuk Lymphoma. 2017 Jan 13:1-13. doi: 10.1080/10428194.2016.1271946.
    PubMed     Text format     Abstract available


    December 2016
  5. HOGAN JJ, Loren AW, Denker MG, Mangan JK, et al
    Edema with hypoalbuminemia as a rare manifestation of chronic graft versus host disease after allogeneic hematopoietic cell transplant.
    Leuk Lymphoma. 2016 Dec 21:1-3. doi: 10.1080/10428194.2016.1270451.
    PubMed     Text format    


    November 2016
  6. SHINOHARA A, Inamoto Y, Kurosawa S, Hiramoto N, et al
    High non-relapse mortality and low relapse incidence in gender-mismatched allogeneic hematopoietic stem cell transplantation from a parous female donor with a male child.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  7. CHOE H, Martin P
    Frontline autologous stem cell transplant for high-risk follicular lymphoma: forever elusive?
    Leuk Lymphoma. 2016.
    PubMed     Text format    


    October 2016
  8. PHILLIPS AA
    Hematopoeitic stem cell transplantation for adult T cell leukemia-lymphoma: Who is the best candidate?
    Leuk Lymphoma. 2016.
    PubMed     Text format    


  9. STETTLER J, Novak U, Baerlocher GM, Seipel K, et al
    Autologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacy.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  10. OGUNNIYI A, Rodriguez M, Devlin S, Adel N, et al
    Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  11. WANG W, Foerner E, Buss E, Jauch A, et al
    Hematopoietic stem cells can be separated from leukemic cells in a subgroup of adult acute lymphoblastic leukemia patients.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  12. ZHAO XS, Qin YZ, Liu YR, Chang YJ, et al
    The impact of minimal residual disease prior to unmanipulated haploidentical hematopoietic stem cell transplantation in patients with acute myeloid leukemia in complete remission.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


    September 2016
  13. GUPTA R, Kumar L, Dahiya M, Mathur N, et al
    Minimal residual disease evaluation in autologous stem cell transplantation recipients with multiple myeloma.
    Leuk Lymphoma. 2016.
    PubMed     Text format    


  14. TOKUNAGA M, Uto H, Takeuchi S, Nakano N, et al
    Newly identified poor prognostic factors for adult T-cell leukemia-lymphoma treated with allogeneic hematopoietic stem cell transplantation.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


    August 2016
  15. SORIGUE M, Sancho JM, Morgades M, Moreno M, et al
    Relapse risk after autologous stem cell transplantation in patients with lymphoma based on CD34+ cell dose.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  16. SHARMA P, Shinde SS, Damlaj M, Hefazi Rorghabeh M, et al
    Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  17. KOLDEHOFF M, Ross SR, Duhrsen U, Beelen DW, et al
    Early CMV-replication after allogeneic stem cell transplantation is associated with a reduced relapse risk in lymphoma.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  18. ASLAN A, Aras T, Ozdemir E
    Successful treatment of relapsed/refractory Hodgkins lymphoma with nivolumab in a heavily pretreated patient with progressive disease after both autologous and allogeneic stem cell transplantation.
    Leuk Lymphoma. 2016.
    PubMed     Text format    


  19. MONTORO J, Sanz J, Sanz GF, Sanz MA, et al
    Advances in haploidentical stem cell transplantation for hematologic malignancies.
    Leuk Lymphoma. 2016;57:1766-75.
    PubMed     Text format     Abstract available


    July 2016
  20. BALASSA K, Krahling T, Remenyi P, Batai A, et al
    Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


    June 2016
  21. BRAMMER JE, Khouri I, Marin D, Ledesma C, et al
    Stem cell transplantation outcomes in lymphoblastic lymphoma.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  22. MAYER S, Pastores SM, Riedel E, Maloy M, et al
    Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peritransplant period.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  23. BEAUVERD Y, Cortes B, Masouye I, Chalandon Y, et al
    Complete remission of disseminated granulomatous dermatitis related to chronic eosinophilic leukemia following allogeneic stem cell transplantation.
    Leuk Lymphoma. 2016.
    PubMed     Text format    


  24. BAETZ T, Chen BE, Couban S, Tom Kouroukis C, et al
    Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


    May 2016
  25. SHIPOUNOVA IN, Petinati NA, Bigildeev AE, Drize NJ, et al
    Alterations of the bone marrow stromal microenvironment in adult patients with acute myeloid and lymphoblastic leukemias before and after allogeneic hematopoietic stem cell transplantation.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  26. ISIDORI A, Christofides A, Visani G
    Novel regimens prior to autologous stem cell transplantation for the management of adults with relapsed/refractory non-Hodgkin lymphoma and Hodgkin lymphoma: alternatives to BEAM conditioning.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  27. MICHALLET M, Sobh M, Labussiere H, Lombard C, et al
    Potential anti-leukemic activity of iron chelation after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia.
    Leuk Lymphoma. 2016.
    PubMed     Text format    


  28. FIALA MA, Slade M, Wang S, Park S, et al
    The impact of diabetes mellitus and other comorbidities on hematopoietic stem cell collection and hematologic recovery post-transplantation.
    Leuk Lymphoma. 2016.
    PubMed     Text format    


  29. THOMAS CM, Ippoliti C, Roboz GJ, Feldman E, et al
    Clofarabine as a bridge to hematopoietic stem cell transplant.
    Leuk Lymphoma. 2016.
    PubMed     Text format    


  30. ITONAGA H, Taguchi J, Taguchi M, Taniguchi H, et al
    Adult T-cell leukemia/lymphoma in donor cells responding to second allogeneic hematopoietic stem cell transplantation using unrelated cord blood: the Nagasaki Transplant Group experience.
    Leuk Lymphoma. 2016.
    PubMed     Text format    


  31. CHIEW MY, Boo NY, Voon K, Cheong SK, et al
    Generation of a MLL-AF9-specific stem cell model of acute monocytic leukemia.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  32. GRAIN A, Sirvent A, Strullu M, Francoise M, et al
    Sustained responses after clofarabine-based sequential allogeneic stem cell transplantation in children with high-risk, relapse and/or refractory acute myeloid leukemia or juvenile myelomonocytic leukemia: a study on behalf of the French society of bo
    Leuk Lymphoma. 2016.
    PubMed     Text format    


  33. VON TRESCKOW B, Morschhauser F, Szer J, Eichenauer DA, et al
    Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation.
    Leuk Lymphoma. 2016.
    PubMed     Text format    


    April 2016
  34. WEISEL K, Doyen C, Dimopoulos M, Yee A, et al
    A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  35. NINKOVIC S, Cheah CY, Lasocki A, Harrison SJ, et al
    Engraftment syndrome manifesting as acute brachial neuropathy following high-dose chemotherapy for management of plasma cell myeloma.
    Leuk Lymphoma. 2016.
    PubMed     Text format    


  36. FEDERMANN B, Bonzheim I, Schittenhelm J, Quintanilla-Martinez L, et al
    EBV-negative aggressive B-cell lymphomas of donor origin after allogeneic hematopoietic stem cell transplantation: a report of three cases.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


    March 2016
  37. WAHBA MR, Surapaneni M, Chandrasekar PH
    Successful therapy with Ledipasvir/Sofosbuvir for hepatitis C reactivation in a hematopoietic stem cell transplant recipient.
    Leuk Lymphoma. 2016.
    PubMed     Text format    


  38. CIRRONE F, Ippoliti C, Wang H, Zhou XK, et al
    Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  39. LOPEZ JP, Shore TB
    Bendamustine and stem-cell mobilization: not so bad!
    Leuk Lymphoma. 2016.
    PubMed     Text format    


    February 2016
  40. TIAN H, Liu L, Chen J, Xu Y, et al
    Haploidentical hematopoietic stem cell transplant in paroxysmal nocturnal hemoglobinuria.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  41. WANQUET A, Crocchiolo R, Furst S, Granata A, et al
    The efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100 mg/m intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-risk mye
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  42. STYCZYNSKI J, Czyzewski K, Wysocki M, Zajac-Spychala O, et al
    Micafungin in invasive fungal infections in children with acute leukemia or undergoing stem cell transplantation.
    Leuk Lymphoma. 2016.
    PubMed     Text format    


  43. KUANG P, Liu T, Pan L, Zhu H, et al
    Sustaining integrating imatinib and interferon-alpha into maintenance therapy improves survival of patients with Philadelphia positive acute lymphoblastic leukemia ineligible for allogeneic stem cell transplantation.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  44. HATTORI N, Yamamoto K, Kawaguchi Y, Fujiwara S, et al
    Early relapse of severe chronic active Epstein-Barr virus infection with posterior reversible encephalopathy syndrome after reduced intensity stem cell transplantation with umbilical cord blood.
    Leuk Lymphoma. 2016.
    PubMed     Text format    


  45. GAC AC, Azar N, Daguindau E, Cartron G, et al
    Does bendamustine impact the mobilization of peripheral blood stem cells? A multicenter retrospective study of 23 cases.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  46. BALZAROTTI M, Brusamolino E, Angelucci E, Carella AM, et al
    B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL).
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


    January 2016
  47. KONUMA T, Kato S, Oiwa-Monna M, Ishii H, et al
    Comparison of graft-versus-host disease-free, relapse-free survival of transplantation using matched sibling donor, matched unrelated donor or unrelated cord blood after myeloablative conditioning for adult patients with hematological malignancies.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  48. POREBA M, Gac P, Usnarska-Zubkiewicz L, Pilecki W, et al
    Echocardiographic evaluation of the early cardiotoxic effect of hematopoietic stem cell transplantation in patients with hematologic malignancies.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  49. LANDAU H, Wood K, Chung DJ, Koehne G, et al
    Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation.
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


  50. SAILLARD C, El Cheikh J, Granata A, Coso D, et al
    Histone deacetylase inhibitor abexinostat (S78454/PCI-24781) as a successful approach in a case of refractory peripheral angio-immunoblastic T-cell lymphoma, as a bridge to reduced intensity conditioning haplo-identical allogenic stem cell transplant.
    Leuk Lymphoma. 2016.
    PubMed     Text format    


  51. AMORIM S, Fleury I, Mounier N, Harel S, et al
    Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment.
    Leuk Lymphoma. 2016.
    PubMed     Text format    


  52. BRUNO B, Auner HW, Gahrton G, Garderet L, et al
    Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting).
    Leuk Lymphoma. 2016.
    PubMed     Text format     Abstract available


    December 2015
  53. GARG S, Shanmukhaiah C, Ghosh K, Madkaikar M, et al
    Cell signaling in putative leukemic stem cells and blast population in acute myeloid leukemia.
    Leuk Lymphoma. 2015.
    PubMed     Text format    


  54. SUNDARARAJAN S, Chen H, Kumar A, Tus K, et al
    Donor-derived marginal zone lymphoma following reduced-intensity allogeneic peripheral blood stem cell transplant.
    Leuk Lymphoma. 2015.
    PubMed     Text format    


  55. DEOTARE U, Kim DD, Michelis FV, Lipton JH, et al
    Allogeneic Hematopoietic Stem Cell Transplantions in Blastic Plasmacytoid Dendritic Cell Neoplasm in first complete remission: an effective therapy for a rare disease.
    Leuk Lymphoma. 2015.
    PubMed     Text format    


  56. BROGILE L, Hijiya N, Helenowski IB, Dilley K, et al
    Long-term follow-up of children with chronic myeloid leukemia after hematopoietic stem cell transplantation and tyrosine kinase inhibitor therapy.
    Leuk Lymphoma. 2015.
    PubMed     Text format    


    August 2015
  57. FUNGPIPAT P, Sophonphan J, Sosothikul D, Suppipat K, et al
    Redefine Clinical Risk Classification in Children with Precursor B Cell Acute Lymphoblastic Leukemia using Pretreatment Absolute Lymphocyte Count.
    Leuk Lymphoma. 2015.
    PubMed     Text format    


  58. ILIFF A, Divine C, Diaz F, Aljitawi O, et al
    Adequacy of Peripheral Blood Stem Cell Mobilization in Patients with Relapsed B Cell Non Hodgkin Lymphoma Treated with Bendamustine.
    Leuk Lymphoma. 2015.
    PubMed     Text format    


    May 2015
  59. TESTA U, Pelosi E
    MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemias.
    Leuk Lymphoma. 2015;56:1466-74.
    PubMed     Text format     Abstract available


    March 2015
  60. KOLDEHOFF M, Lindemann M, Opalka B, Bauer S, et al
    Cytomegalovirus induces apoptosis in acute leukemia cells as a virus-versus-leukemia function.
    Leuk Lymphoma. 2015.
    PubMed     Text format     Abstract available


  61. PLESA A, Elhamri M, Clapisson G, Mattei E, et al
    Higher percentage of CD34 + CD38- cells detected by multiparameter flow cytometry from leukapheresis products predicts unsustained complete remission in acute myeloid leukemia.
    Leuk Lymphoma. 2015;56:622-9.
    PubMed     Text format     Abstract available


  62. UEDA M, Xie H, Sandhu RK, Walter RB, et al
    Factors associated with early reinduction chemotherapy for adults with acute myeloid leukemia.
    Leuk Lymphoma. 2015;56:782-4.
    PubMed     Text format    


    November 2014
  63. NG SB, Ohshima K, Selvarajan V, Huang G, et al
    EBV-associated T/NK-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal NK/T-cell lymphoma but shows distinctive stem cell-like phenotype.
    Leuk Lymphoma. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: